Maine Cannabis Legislation

LD1942 establishes an excise tax on prerolled cannabis cigarettes and alters the tax on intoxicating hemp products, impacting consumers and operators in Maine.

LD1820 simplifies Maine's adult-use cannabis regulations, impacting operators and consumers through streamlined business practices and potentially lower costs.

LD948 streamlines Maine's cannabis regulations, potentially easing access for patients and consumers while reducing burdens for operators.

LD1488 mandates adult-use cannabis testing in Maine, enhancing public safety for consumers and ensuring product quality from operators.

LD1609 bans individuals and companies linked to federally recognized criminal organizations from Maine's medical and adult-use cannabis programs, impacting industry integrity and public safety.

LD1669 establishes a Cannabis Advisory Council in Maine, providing a formal body for stakeholder input on cannabis policy for patients, consumers, and operators.

LD1840 allows medical cannabis caregivers to deliver directly to patients, expanding access for Maine's medical cannabis users.

LD1897 permits outdoor cannabis cultivation for both medical and adult-use markets in Maine, expanding options for operators and potentially lowering consumer costs.

LD1654 exempts certain adult-use cannabis sales and transfers from excise tax, potentially lowering consumer prices and reducing costs for Maine operators.

LD1920 prohibits the sale of intoxicating hemp products to individuals under 21, aligning age restrictions with adult-use cannabis and enhancing public health protections for Maine youth.

LD584 made Maine's OCP Director an appointed, Legislature-confirmed position, increasing accountability for cannabis regulation but failed to pass.

LD1983 failed, leaving intoxicating hemp-derived products unregulated under Maine's adult-use cannabis laws, impacting public safety and youth access.

LD1960 exempted ingestible hemp products from tobacco taxes, impacting consumer prices and the regulatory landscape for hemp businesses in Maine.

LD1672 made participation in Maine's adult-use cannabis tracking system voluntary, impacting consumer safety oversight and market data for operators.

LD1620 would have altered adult-use cannabis testing regulations in Maine, impacting product safety for consumers and compliance burdens for operators.

LD1535 required permits for high electrical usage to combat illegal cannabis operations in Maine, impacting consumers and the legal market by failing to pass.

LD544 exempted medical cannabis sales from taxation, reducing costs for Maine patients.

LD1869 allowed Maine municipalities to enact a local sales tax on recreational cannabis, aiming to lower property taxes.

LD1831 created a micro cannabis facility license to support small adult-use businesses in Maine, but it failed to pass.

LD1314 protected Maine cannabis workers' access to personal credit, preventing discrimination based on industry affiliation.

LD104 mandated testing for medical cannabis in Maine, aiming to protect patient health by ensuring product safety and quality.

LD1567 mandated labeling of radiation/ozonation for adult-use cannabis and equipment inspection, impacting consumer information and product safety in Maine.

LD1717 required background checks for medical cannabis providers in Maine, impacting patient access and public safety.

LD302, failed, would have allowed cannabis businesses to operate in municipalities that previously opted out, impacting consumer access and local control.

LD392 failed, preventing changes to Maine's cannabis laws that could have impacted patients, consumers, and operators.

LD959 required better cannabis testing criteria and processes in Maine, impacting consumer safety and product quality.

LD1455 aimed to prevent illegal cannabis growing operations in Maine, impacting public safety and the regulated market.

LD1608 aimed to combat illicit cannabis operations in Maine, impacting the legal market's integrity and public safety.

LD1320, which failed, aimed to prevent illicit cannabis cultivation and trafficking within Maine's regulated market, impacting public safety and market integrity.

LD347 would have given Maine municipalities a share of adult-use cannabis sales and excise tax revenue, impacting local funding for public services.

LD1559 authorized medical cannabis farmers' markets in Maine, which would have expanded patient access and supported small-scale cultivators.

LD903 failed, meaning Maine's cannabis advertising regulations remain unchanged, impacting how consumers learn about products and how businesses market them.

LD859 directed the Treasurer to explore banking solutions for Maine's cannabis industry, which matters for operators and the state's economy.

LD368 failed, meaning Maine's cannabis industry lacks specific regulations for radiation machines and similar equipment, impacting product safety oversight.

LD929 allowed medical cannabis reciprocity for out-of-state seniors and veterans, expanding access but failing to pass in Maine.

LD1038 increased the maximum term for medical cannabis certifications to two years, reducing renewal burdens for Maine patients.

LD177 established a municipal cannabis revenue sharing program in Maine, impacting local government funding and the distribution of cannabis tax revenue.

LD548 failed, leaving intoxicating hemp products unregulated in Maine, impacting consumer safety and market fairness.